Heathbridge Capital Management Ltd. Has $12.28 Million Holdings in Zoetis Inc. (NYSE:ZTS)

Heathbridge Capital Management Ltd. lessened its position in Zoetis Inc. (NYSE:ZTS) by 0.6% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 62,850 shares of the company’s stock after selling 400 shares during the quarter. Zoetis makes up about 4.7% of Heathbridge Capital Management Ltd.’s investment portfolio, making the stock its 9th largest holding. Heathbridge Capital Management Ltd.’s holdings in Zoetis were worth $12,280,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the company. PFW Advisors LLC purchased a new position in shares of Zoetis during the first quarter valued at approximately $1,845,000. RFG Advisory LLC bought a new stake in Zoetis in the first quarter worth $307,000. Gulf International Bank UK Ltd grew its stake in shares of Zoetis by 0.7% in the first quarter. Gulf International Bank UK Ltd now owns 38,217 shares of the company’s stock worth $6,466,000 after acquiring an additional 251 shares during the last quarter. Clarus Wealth Advisors increased its holdings in shares of Zoetis by 24.1% during the first quarter. Clarus Wealth Advisors now owns 3,606 shares of the company’s stock valued at $588,000 after acquiring an additional 700 shares in the last quarter. Finally, MJP Associates Inc. ADV purchased a new position in shares of Zoetis in the 1st quarter worth about $232,000. 92.80% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Argus raised shares of Zoetis to a “strong-buy” rating in a report on Friday, August 9th. Piper Sandler boosted their price objective on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, August 14th. Stifel Nicolaus lifted their target price on Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a report on Wednesday, September 18th. JPMorgan Chase & Co. boosted their price target on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, BTIG Research increased their price objective on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, August 12th. Ten analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $221.44.

Zoetis Stock Down 1.8 %

Zoetis stock opened at $191.00 on Friday. Zoetis Inc. has a one year low of $144.80 and a one year high of $201.92. The stock has a fifty day moving average of $188.82 and a 200 day moving average of $176.80. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.09 and a current ratio of 3.45. The stock has a market cap of $87.15 billion, a PE ratio of 36.80, a price-to-earnings-growth ratio of 2.99 and a beta of 0.89.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.07. The firm had revenue of $2.36 billion for the quarter, compared to analysts’ expectations of $2.31 billion. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The business’s quarterly revenue was up 8.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.41 EPS. As a group, sell-side analysts predict that Zoetis Inc. will post 5.83 EPS for the current year.

Zoetis Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be paid a $0.432 dividend. The ex-dividend date is Thursday, October 31st. This represents a $1.73 annualized dividend and a dividend yield of 0.90%. Zoetis’s dividend payout ratio (DPR) is 33.14%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.